Brief: Zoetis Receives European Commission Marketing Authorization For Portela® (Relfovetmab) To Alleviate Pain Associated With Osteoarthritis In Cats
29/10/2025 13:06
Zoetis Inc ZTS.N: ZOETIS RECEIVES EUROPEAN COMMISSION MARKETING AUTHORIZATION FOR PORTELA® (RELFOVETMAB) TO ALLEVIATE PAIN ASSOCIATED WITH OSTEOARTHRITIS IN CATS ZOETIS INC - ANTICIPATES PORTELA AVAILABILITY IN EU IN 2026 Source text: ID:nBw5n10C1a Further company coverage: ZTS.N